Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yin deficiency syndrome is a **theoretical diagnostic pattern in Traditional Chinese Medicine (TCM)**, not a molecular or pharmacological target such as a receptor, enzyme, or transporter[3][7][1]. It describes a state of suboptimal health or imbalance characterized by insufficient "Yin" (the cooling, nourishing, and moistening aspect of the body), leading to symptoms like internal heat, dryness, night sweats, dry mouth and skin, insomnia, restlessness, and a rapid, thin pulse[1][3][5][7]. In TCM, Yin deficiency may affect different organ systems (e.g., Kidney, Liver, Heart, Lungs, Stomach) and is commonly attributed to overwork, inadequate sleep, chronic illness, excessive sexual activity, and dietary or emotional factors[1][7][3]. While recent studies have explored possible associations between TCM syndromes like Yin deficiency and certain metabolic or immune parameters in diseases such as rheumatoid arthritis and lung cancer, Yin deficiency syndrome itself does not correspond to any biochemically defined molecule, receptor, or gene and thus is **not a therapeutic molecular target** as conventionally understood in biomedical sciences[3][2][6]. Treatment principle in TCM focuses on "nourishing Yin" using herbal formulas like Liu Wei Di Huang Wan or Zuo Gui Wan, but these remedies do not act on a discrete molecular entity known as a drug target[1][7]. **Summary of structuring information:** - Yin deficiency syndrome is a diagnostic concept/pattern, not a target molecule or receptor. - There is no canonical abbreviation in biomedical naming conventions. - It does not fit within molecular classification families or have defined biological or pharmacological roles at the molecular level. - There are no known direct biomarkers, molecular interacting drugs, or safety concerns as would be listed for a discrete target. - The concept is central to TCM but should not be treated as a molecule, receptor, or typical “therapeutic target.” This entry is **incorrect for target identification purposes** because it does not represent a molecular entity but rather a diagnostic framework unique to TCM[3][7][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yin deficiency syndrome.